Detalhe da pesquisa
1.
Medically Tailored Meals to Address the Health Consequences of Food Insecurity.
N Engl J Med
; 390(9): 775-776, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38407267
2.
"I was able to eat what I am supposed to eat"-- patient reflections on a medically-tailored meal intervention: a qualitative analysis.
BMC Endocr Disord
; 20(1): 10, 2020 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959176
3.
Medically Tailored Meal Delivery for Diabetes Patients with Food Insecurity: a Randomized Cross-over Trial.
J Gen Intern Med
; 34(3): 396-404, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30421335
4.
Medically tailored meals for food insecurity and type 2 diabetes: Protocol for the Food as Medicine for Diabetes (FAME-D) trial.
Contemp Clin Trials
; 124: 107039, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36470556
5.
Association Between Receipt of a Medically Tailored Meal Program and Health Care Use.
JAMA Intern Med
; 179(6): 786-793, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31009050
6.
Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders.
Neuropsychopharmacology
; 33(3): 574-87, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17460614
7.
Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia.
Pharmacol Biochem Behav
; 91(1): 47-58, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18621075
8.
Meal Delivery Programs Reduce The Use Of Costly Health Care In Dually Eligible Medicare And Medicaid Beneficiaries.
Health Aff (Millwood)
; 37(4): 535-542, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29608345
9.
SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.
Neuropsychopharmacology
; 32(1): 17-34, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16936709
10.
Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
Neuropsychopharmacology
; 30(11): 1963-85, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15956994
11.
Unified Approach Needed to Implement Nutrition Support Services-Reply.
JAMA Intern Med
; 179(9): 1303, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31476005
12.
SAR110894, a potent histamine H3-receptor antagonist, displays procognitive effects in rodents.
Pharmacol Biochem Behav
; 102(2): 203-14, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22542742
13.
SL65.0155, a novel 5-hydroxytryptamine(4) receptor partial agonist with potent cognition-enhancing properties.
J Pharmacol Exp Ther
; 302(2): 731-41, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12130738